Date published: 2025-10-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

PalGly (CAS 2441-41-0)

0.0(0)
Write a reviewAsk a question

Alternate Names:
N-(1-Oxohexadecyl)glycine; N-Hexadecanoylglycine; Hexadecanoylaminoacetic acid
Application:
PalGly is An endogenous signaling lipid that modulates calcium influx and NO production
CAS Number:
2441-41-0
Purity:
≥98%
Molecular Weight:
313.48
Molecular Formula:
C18H35NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Palmitoyl glycine (PalGly) is a lipid-amino acid conjugate extensively studied for its role in cell signaling and membrane interactions. This molecule consists of palmitic acid, a saturated long-chain fatty acid, linked to glycine, an amino acid. PalGly is part of a broader class of lipid-modified amino acids and peptides that modulate various biological functions by incorporating into cell membranes and influencing membrane-associated processes. In research, PalGly is used to explore its effects on membrane fluidity and the organization of lipid microdomains. Its amphiphilic nature allows it to integrate into lipid bilayers, potentially altering the physical properties of membranes and affecting the activity of membrane-bound proteins, including receptors and enzymes. PalGly also serves as a model compound for investigating the biochemical mechanisms underlying lipid-protein interactions. Researchers utilize this molecule to study how lipid modifications can affect protein localization, stability, and function. Furthermore, PalGly is employed in the development of novel biomaterials and drug delivery systems. Its ability to enhance the bioavailability and stability of agents makes it a valuable component in the formulation of lipid-based delivery vehicles. Overall, PalGly is a critical tool in lipidomics and cell biology, advancing our understanding of lipid-mediated signaling and membrane dynamics.


PalGly (CAS 2441-41-0) References

  1. Pivotal role of water in the mechanism of P450BM-3.  |  Haines, DC., et al. 2001. Biochemistry. 40: 13456-65. PMID: 11695892
  2. Conformational equilibrium of cytochrome P450 BM-3 complexed with N-palmitoylglycine: a replica exchange molecular dynamics study.  |  Ravindranathan, KP., et al. 2006. J Am Chem Soc. 128: 5786-91. PMID: 16637647
  3. Conformational dynamics of the cytochrome P450 BM3/N-palmitoylglycine complex: the proposed 'proximal-distal' transition probed by temperature-jump spectroscopy.  |  Brenner, S., et al. 2007. J Phys Chem B. 111: 7879-86. PMID: 17571881
  4. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.  |  Hegde, A., et al. 2007. Biochemistry. 46: 14010-7. PMID: 18004886
  5. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.  |  Chen, CK., et al. 2008. J Biol Inorg Chem. 13: 813-24. PMID: 18392864
  6. Orphan endogenous lipids and orphan GPCRs: a good match.  |  Bradshaw, HB., et al. 2009. Prostaglandins Other Lipid Mediat. 89: 131-4. PMID: 19379823
  7. Structural evidence: a single charged residue affects substrate binding in cytochrome P450 BM-3.  |  Catalano, J., et al. 2013. Biochemistry. 52: 6807-15. PMID: 23829560
  8. Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells.  |  Baumann, J., et al. 2018. Oncotarget. 9: 27133-27150. PMID: 29930756
  9. N-Palmitoylglycine and other N-acylamides activate the lipid receptor G2A/GPR132.  |  Foster, JR., et al. 2019. Pharmacol Res Perspect. 7: e00542. PMID: 31768260

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PalGly, 10 mg

sc-215664
10 mg
$185.00

PalGly, 50 mg

sc-215664A
50 mg
$700.00